Anti-Aging · Reference
How Long Does FOXO4-DRI Take to Work? What the Mouse Studies Measured, and When
This page sets out what the studies measured and over what period, why none of it is a timeline for you, what "working" would even mean for a senolytic, and what to track instead.

Treatments mentioned
No study has measured how long FOXO4-DRI takes to work in people, because no person has been treated with it in a published study. The evidence is mouse and cell work: in the 2017 Cell paper that introduced it, aged mice received a short course of intermittent injection into the abdominal cavity and their fitness, fur density and kidney function were measured over days to a few weeks. A mouse ages in two years, and there is no established way to convert that to a human timescale. Senescent cell clearance, if it happens, is not something a person would feel, so there is no timeline to promise. Compounded FOXO4-DRI is not FDA approved.
This page sets out what the studies measured and over what period, why none of it is a timeline for you, what "working" would even mean for a senolytic, and what to track instead.
How Long Does FOXO4-DRI Take to Work? What the Mouse Studies Measured, and When
The short answer
| Study | What it used | Over what period | What it measured |
|---|---|---|---|
| Cell, 2017 (de Keizer laboratory) | Chemotherapy-treated mice, fast-aging mice and naturally old mice | A short course of intermittent intraperitoneal injection; effects measured over days to a few weeks | Liver toxicity markers, running-wheel activity, fur density, urinary albumin |
| Aging, 2020 | Aged mice, plus observational human testicular tissue | Not a human treatment study | Senescent Leydig cells and testosterone secretion in mice |
| Naunyn-Schmiedeberg's Archives of Pharmacology, 2023 | Mice with bleomycin-induced lung fibrosis | Animal model | Pathological change and collagen deposition |
| Experimental Gerontology, 2024 | Naturally aged mice | Animal model | Sperm quality and spermatogenesis |
| Frontiers in Bioengineering and Biotechnology, 2021 | Human chondrocytes in a dish | Cell culture | Removal of the senescent fraction |
| Communications Biology, 2025 | Human keloid tissue and cells in a dish | Organ culture and cell models | Apoptosis of senescent fibroblasts |
| Frontiers in Bioengineering and Biotechnology, 2026 | Naturally aged and induced-aging mice | Animal model | Aortic aging markers and aortic function |
Every row is a mouse or a dish. None measured anything a person would notice, and none gives a human time course.
How Long Does FOXO4-DRI Take to Work? What the Mouse Studies Measured, and When
What the study timelines do and do not tell you
The founding mouse work was short by design
The 2017 Cell paper is the source of almost every claim made for FOXO4-DRI. It first tested the peptide against doxorubicin, a chemotherapy drug that induces senescence, and reported that FOXO4-DRI neutralised the chemotherapy's toxicity in mice. It then treated fast-aging mice, which age quickly because of a DNA repair defect, and ordinary old mice, and reported restored running-wheel activity, fur density and kidney function. Treatment was a short course of intermittent intraperitoneal injection, and effects were measured over days to a few weeks after it.
That tells you the experiment was designed around a brief course in an animal whose tissues turn over quickly. It does not tell you that anything happens in a person over a similar period.
The later mouse studies measured tissue, not a felt effect
The Leydig cell, lung fibrosis, sperm quality and aortic studies each looked at markers in a specific tissue: senescent cell counts, collagen, testosterone secretion in mice, sperm parameters, aortic function. These are measurements made by researchers on tissue, not outcomes a person would feel day to day. The full detail is in FOXO4-DRI benefits.
The human-cell studies have no clock that applies to you
Cells in a dish respond on a laboratory timetable. The 2021 chondrocyte work and the 2025 keloid work show that FOXO4-DRI can act on senescent human cells under culture conditions. They say nothing about how long an injected dose takes to reach tissue in a living person, or whether it does.
How Long Does FOXO4-DRI Take to Work? What the Mouse Studies Measured, and When
Why mouse timelines do not translate
| Factor | In the mouse work | At Pepti |
|---|---|---|
| Route | Intraperitoneal injection, into the abdominal cavity | Subcutaneous, into the fat layer |
| Schedule | A short intermittent course | Once daily Monday through Friday, about four weeks per vial |
| Lifespan of the species | About two years | Decades |
| Human pharmacokinetics | Not studied | Not studied |
| What was measured | Tissue markers and mouse behaviour | Nothing has been measured in people |
There is no human pharmacokinetic study, so nobody knows how long FOXO4-DRI stays in the body after a subcutaneous dose, how much reaches any tissue, or whether it clears senescent cells in people at all. The subcutaneous schedule is a clinical convention, not a translated one. Pepti's directions are described in FOXO4-DRI dosage.
How Long Does FOXO4-DRI Take to Work? What the Mouse Studies Measured, and When
What "working" would even mean
For a recovery peptide, a sore tendon feeling better is a reasonable marker. For a senolytic there is no comparable signal a patient can observe. FOXO4-DRI is not a stimulant, not a sedative and not an anti-inflammatory in the direct sense, and there is no described acute effect. Most people should expect to notice nothing during a first vial, and that is consistent with the mechanism rather than a sign of failure. What is most likely to be noticeable early is the injection site.
Some sources quote inflammatory markers as a way to "see" a senolytic work. Whether any marker is meaningful for FOXO4-DRI has not been studied. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.
How Long Does FOXO4-DRI Take to Work? What the Mouse Studies Measured, and When
After a course
There is no withdrawal and no rebound described in the animal work. Whether any senescent cells removed would re-accumulate, and how fast, is unknown in humans. Prescribers generally treat FOXO4-DRI as an intermittent course rather than a continuous medication, which is why the directions are five days a week and a vial is sized at about four weeks. Whether a further vial is prescribed is reviewed with each refill, and with an experimental compound the answer can reasonably be no.
How Long Does FOXO4-DRI Take to Work? What the Mouse Studies Measured, and When
What your directions look like
| What the label shows | Value |
|---|---|
| Product | FOXO4-DRI, 5 mL multi-dose vial at 2 mg/mL (10 mg per vial) |
| Typical directions | Inject 0.25 mL (25 units) subcutaneously once daily Monday through Friday |
| FOXO4-DRI per dose | 0.5 mg (2 mg/mL x 0.25 mL, math only) |
| Doses per vial | 20, about four weeks |
| Price | $229/mo, all-in |
Refills run every 28 days, one vial per fill. Vials ship ready to use, refrigerated with ice packs, with sterile syringes and alcohol prep pads. Your physician sets your directions after reviewing your intake, and they are printed on the vial.
How Long Does FOXO4-DRI Take to Work? What the Mouse Studies Measured, and When
What to track, and when to message your care team
Because there is nothing specific to feel, a record matters more than usual. It is the only way to separate a real change from expectation or an ordinary good week.
| Keep a note of | Why |
|---|---|
| What you hoped would change, written before you start | So you are not choosing afterwards from whatever moved |
| Sleep, illness, training and stress | The ordinary causes of feeling better or worse |
| Injection-site redness, soreness or bruising | The main thing reported clinically |
| Any rash or hives away from the site | Immune reactions to the peptide's unusual chemistry are a theoretical concern |
| Any new breathing symptom | A 2023 mouse study raised a question about senolytics and pulmonary hypertension |
Message your care team about an injection-site reaction that does not settle or anything new. Facial or throat swelling, widespread rash or difficulty breathing is an emergency: call 911, then tell your physician. If you think you injected far more than your directions, call Poison Control at 1-800-222-1222 and message your care team. Do not change your dose or schedule to try to make it work faster.
The general picture across peptides is in how long do peptides take to work.
How Long Does FOXO4-DRI Take to Work? What the Mouse Studies Measured, and When
What the evidence shows, honestly
FOXO4-DRI has an unusually well-defined mechanism for a compounded peptide, confirmed structurally in a 2025 Nature Communications paper that showed it binding the same region of p53 the natural FOXO4 uses. Around that sits a small set of consistent mouse and cell studies and no human data at all: no randomised trial, no non-randomised trial, no dose-finding, pharmacokinetic or safety study. Any source that tells you when you will notice FOXO4-DRI working is inventing a timeline.
On regulation: FOXO4-DRI does not appear in Category 1, 2 or 3 of the FDA's 503A nominated-substances document updated 14 May 2026, is not on the FDA's significant-safety-risk page, and has not been before the advisory committee. The FDA has not evaluated it either way. Compounded medications are not FDA approved. The reference is what is FOXO4-DRI.
How Long Does FOXO4-DRI Take to Work? What the Mouse Studies Measured, and When
Where to get FOXO4-DRI prescribed
FOXO4-DRI cannot be bought legitimately without a prescription. Sites selling it "for research use only" are not accountable for identity, purity, sterility or concentration. The prescription route:
- Complete a free online intake covering your history, medications and what you want help with.
- A physician licensed in your state reviews it, usually within 24 hours.
- If it is appropriate, a PCAB-accredited, FDA-registered US 503A compounding pharmacy prepares it to that prescription. Lot test results are published at /quality/lab-results.
- It ships refrigerated with your directions printed on the vial.
- Your physician stays reachable for questions and side effects.
Pepti is cash-pay, does not bill insurance and charges no membership fee. It prescribes in most US states, not currently in Oklahoma, and the assessment confirms availability for your state. Step by step: how to get FOXO4-DRI prescribed online.
References
What this is based on.
References
- Baar MP, Brandt RMC, Putavet DA et al.. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging · Cell (2017) · PMID 28340339
- Bourgeois B, Spreitzer E, Platero-Rochart D et al.. The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI · Nature Communications (2025) · PMID 40593617
- Zhang C, Xie Y, Chen H et al.. FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice · Aging (Albany NY) (2020) · PMID 31959736
- Huang Y, He Y, Makarcyzk MJ et al.. Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes · Frontiers in Bioengineering and Biotechnology (2021) · PMID 33996787
- Liu Y, Hou Q, Wang R et al.. FOXO4-D-Retro-Inverso targets extracellular matrix production in fibroblasts and ameliorates bleomycin-induced pulmonary fibrosis in mice · Naunyn-Schmiedeberg's Archives of Pharmacology (2023) · PMID 37074394
- Li Y, Zhang C, Cheng H et al.. FOXO4-DRI improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells · Experimental Gerontology (2024) · PMID 39025385
- Hu Z, Li F, Hu C et al.. FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway · Frontiers in Bioengineering and Biotechnology (2026) · PMID 41625068
- Kong YX, Li ZS, Liu YB et al.. FOXO4-DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation · Communications Biology (2025) · PMID 39994346
- Born E, Lipskaia L, Breau M et al.. Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression · Circulation (2023) · PMID 36515093
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Common questions
How Long Does FOXO4-DRI Take to Work? What the Mouse Studies Measured, and When, answered.
No study has measured that in people, because no person has been treated in a published study. The 2017 mouse work used a short intermittent course and measured effects over days to a few weeks in animals that age in two years. That is not a human timeline.
Probably not. There is no described acute effect, and senescent cell clearance, if it happens, is not something a person would feel. Noticing nothing during a first vial is consistent with the mechanism.
The founding 2017 mouse study used a short course of intermittent intraperitoneal injection and measured over days to a few weeks. The later studies were mouse models and cell cultures. There are no human studies to give a duration.
At Pepti, one vial lasts about four weeks: 20 doses of 0.25 mL, once daily Monday through Friday. Whether a further vial follows is reviewed with each refill.
Unknown. No human pharmacokinetic study exists. The D-amino acid design is meant to make it last longer than a natural peptide, but that has not been measured in people.
No. Take the dose printed on your vial, on the schedule printed on your vial, and tell your care team what you are and are not noticing.
No marker has been validated for it. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.
Prescribers treat it as an intermittent course, loosely mirroring the short intermittent dosing in the mouse work. The weekday schedule is a clinical convention, not a trial result.
No. Compounded medications are not FDA approved, and the FDA has not placed FOXO4-DRI in any 503A category. The free assessment goes to a physician licensed in your state. A consultation does not guarantee a prescription.
Next step
See what a physician recommends for you.
A licensed physician in your state reviews your intake and decides what is appropriate. A consultation does not guarantee a prescription.